<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: PDLI News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=pdli</link><description>Latest Financial News for PDL BioPharma, Inc.</description><language>en-us</language><lastBuildDate>Tue, 22 Dec 2009 11:02:28 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091222/pdli8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1907776601</guid><pubDate>Tue, 22 Dec 2009 11:02:28 Etc/GMT</pubDate></item><item><title>Lilly licenses PDL type 1 diabetes drug candidate (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091221/us_pdl_biopharma_eli_lilly.html?.v=2</link><description>PDL BioPharma Inc. said Monday that Eli Lilly &amp; Co. is licensing its drug candidate teplizumab, an experimental treatment for newly diagnosed type 1 diabetes.</description><guid isPermaLink="false">yahoo_finance/3122163944</guid><pubDate>Mon, 21 Dec 2009 22:53:08 Etc/GMT</pubDate></item><item><title>PDL BioPharma Announces New Licensing Agreement With Eli Lilly (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091221/sf29367.html?.v=1</link><description>PDL BioPharma, Inc. today announced that it has entered into a non-exclusive license agreement with Eli Lilly and Company under PDL&apos;s Queen et al patents with respect to teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules.</description><guid isPermaLink="false">yahoo_finance/4131357914</guid><pubDate>Mon, 21 Dec 2009 21:30:00 Etc/GMT</pubDate></item><item><title>PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091216/pdli8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/85311118</guid><pubDate>Wed, 16 Dec 2009 22:09:15 Etc/GMT</pubDate></item><item><title>No Holiday Goodwill Twixt Biogen and Facet (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=134abs2fq/*http%3A//www.fool.com/investing/value/2009/12/16/no-holiday-goodwill-between-biogen-and-facet.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3640290082</guid><pubDate>Wed, 16 Dec 2009 20:38:03 Etc/GMT</pubDate></item><item><title>The Best Investing Ideas in Health Care (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1317j1eah/*http%3A//www.fool.com/investing/general/2009/12/16/the-best-investing-ideas-in-health-care.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2267818397</guid><pubDate>Wed, 16 Dec 2009 15:26:23 Etc/GMT</pubDate></item><item><title>PDL BioPharma Completes December 15 Special Dividend Payment (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091215/sf26492.html?.v=1</link><description>PDL BioPharma, Inc. today announced that it has paid the December 15, 2009 special dividend payment of $1.67 per share to all stockholders owning shares of PDL as of December 1, 2009.  With this payment, distributions to stockholders for the year ended December 31, 2009 total $2.67 per share.  In January 2010, the Company will make a determination regarding the federal tax characteristics of the Company&apos;s 2009 cash distributions and the allocation between dividend income and return of capital for federal income tax purposes.  This information will be disclosed in a press release, posted on the Company&apos;s website and reported to the Company&apos;s transfer agent for inclusion in Form 1099-DIV to be sent at the end of January to each stockholder of the Company&apos;s stock in 2009.  </description><guid isPermaLink="false">yahoo_finance/3005126217</guid><pubDate>Tue, 15 Dec 2009 21:15:00 Etc/GMT</pubDate></item><item><title>Kovarus hires first technology officer (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12kom8af1/*http%3A//sanfrancisco.bizjournals.com/sanfrancisco/stories/2009/12/07/daily35.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/310768411</guid><pubDate>Wed, 9 Dec 2009 22:05:26 Etc/GMT</pubDate></item><item><title>Seth Klarman&apos;s Biggest Bets (at Investopedia)</title><link>http://us.rd.yahoo.com/finance/external/investopedia/rss/SIG=13ul0pdoc/*http%3A//stocks.investopedia.com/stock-analysis/2009/Seth-Klarmans-Biggest-Bets-PDLI-NWS-FACT-ENZN-THRX-LINTA-BRK.A1208.aspx?partner=YahooSA</link><description></description><guid isPermaLink="false">yahoo_finance/2440384866</guid><pubDate>Tue, 8 Dec 2009 18:25:32 Etc/GMT</pubDate></item><item><title>The Most Undervalued Stocks in the Market (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=135l0pu35/*http%3A//www.fool.com/investing/small-cap/2009/12/07/the-most-undervalued-stocks-in-the-market.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3863680150</guid><pubDate>Mon, 7 Dec 2009 19:16:31 Etc/GMT</pubDate></item><item><title>Our Final Offer (Maybe)! That&apos;s a FACT! (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=130vdu8md/*http%3A//www.fool.com/investing/high-growth/2009/12/04/our-final-offer-maybe-thats-a-fact.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1365530266</guid><pubDate>Fri, 4 Dec 2009 20:29:30 Etc/GMT</pubDate></item><item><title>PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091203/pdli8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3844327404</guid><pubDate>Thu, 3 Dec 2009 11:02:44 Etc/GMT</pubDate></item><item><title>PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091202/pdli8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/796141675</guid><pubDate>Wed, 2 Dec 2009 22:16:44 Etc/GMT</pubDate></item><item><title>PDL BioPharma declares special dividend of $1.67 (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091202/us_pdl_biopharma_dividend.html?.v=1</link><description>Biotechnology company PDL BioPharma Inc. said Wednesday it will pay shareholders a special dividend of $1.67 per share. The dividend will be paid on Dec. 15 to shareholders of record as of Dec. 1.</description><guid isPermaLink="false">yahoo_finance/47375544</guid><pubDate>Wed, 2 Dec 2009 20:52:03 Etc/GMT</pubDate></item><item><title>PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091202/sf19632.html?.v=1</link><description>PDL BioPharma, Inc. today announced that it has established the per share amount of the previously announced $200 million special dividend as $1.67 per share. The dividend will be paid on December 15, 2009 to all holders of the Company&apos;s stock as of the December 1, 2009 record date.</description><guid isPermaLink="false">yahoo_finance/2570022971</guid><pubDate>Wed, 2 Dec 2009 13:30:00 Etc/GMT</pubDate></item><item><title>PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091201/sf19383.html?.v=1</link><description>PDL BioPharma, Inc. today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with $69 million for the fourth quarter of 2008.</description><guid isPermaLink="false">yahoo_finance/3931273917</guid><pubDate>Tue, 1 Dec 2009 22:10:00 Etc/GMT</pubDate></item><item><title>The Redacted Ben Graham (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12htffs0u/*http%3A//www.fool.com/investing/general/2009/11/27/the-redacted-ben-graham.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3025899495</guid><pubDate>Fri, 27 Nov 2009 17:45:13 Etc/GMT</pubDate></item><item><title>PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091125/pdli8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3551342473</guid><pubDate>Wed, 25 Nov 2009 21:53:21 Etc/GMT</pubDate></item><item><title>PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091124/pdli8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1636306090</guid><pubDate>Tue, 24 Nov 2009 11:02:46 Etc/GMT</pubDate></item><item><title>PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091123/sf16300.html?.v=1</link><description>PDL BioPharma, Inc. today announced that NASDAQ has established November 27, 2009 as the ex-dividend date for its $200 million special dividend to stockholders resulting from the securitization transaction completed on November 2, 2009.</description><guid isPermaLink="false">yahoo_finance/3918643316</guid><pubDate>Mon, 23 Nov 2009 21:56:00 Etc/GMT</pubDate></item></channel></rss><!-- c11.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 10:16:03 PST 2009 -->
